We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Symptomatic Endometriosis Study

This study is currently closed to enrollment.

Assess efficacy and safety of three different doses of P2X3 antagonist in women with symptomatic endometriosis

Young Woman Suffering Stomach At Home


AGE: 18 years and over
GENDER: Female
TYPE: Drug Study
CONDITION: Premenopausal, Endometriosis
DEPARTMENT: Obstetrics & Gynecology
LOCATION: UH Cleveland Medical Center

Study Purpose

The purpose of this study is to assess safety and efficacy of BAY 1817080 compared to elagolix and placebo in women with symptomatic endometriosis.

Who Can Participate

Women between 18 and 49 years of age who are premenopausal and are diagnosed with moderate to severe endometriosis may be eligible for this study.